Morgan Stanley’s NuCana NCNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3 | Hold |
2
| – | – | ﹤0.01% | 8377 |
|
|
2026
Q1 | $3 | Sell |
2
-103
| -98% | -$248 | ﹤0.01% | 8248 |
|
|
2025
Q4 | $378 | Buy |
105
+103
| +5,150% | +$426 | ﹤0.01% | 7557 |
|
|
2025
Q3 | $9 | Buy |
+2
| New | +$13 | ﹤0.01% | 8105 |
|
|
2025
Q1 | – | Sell |
-62
| Closed | -$14.7K | – | 8176 |
|
|
2024
Q4 | $14.7K | Buy |
62
+37
| +148% | +$11.5K | ﹤0.01% | 6669 |
|
|
2024
Q3 | $11.6K | Buy |
25
+17
| +213% | +$13.2K | ﹤0.01% | 6673 |
|
|
2024
Q2 | $3.99K | Buy |
8
+7
| +700% | +$5.46K | ﹤0.01% | 6912 |
|
|
2024
Q1 | $1.4K | Buy |
+1
| New | +$1.58K | ﹤0.01% | 7132 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$9.4K | – | 7793 |
|
|
2022
Q4 | $9.4K | Sell |
3
-5
| -63% | -$23K | ﹤0.01% | 6962 |
|
|
2022
Q3 | $40K | Buy |
+8
| New | +$57.7K | ﹤0.01% | 6500 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7912 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$10.9K | – | 8062 |
|
|
2021
Q4 | $13K | Sell |
1
-2
| -67% | -$25.1K | ﹤0.01% | 7382 |
|
|
2021
Q3 | $34K | Sell |
3
-86
| -97% | -$1.01M | ﹤0.01% | 6890 |
|
|
2021
Q2 | $1.24M | Buy |
+89
| New | +$1.57M | ﹤0.01% | 4957 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7274 |
|
|
2020
Q4 | – | Hold |
0
| – | -$3K | – | 7081 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6515 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6680 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6653 |
|
|
2019
Q3 | – | Hold |
0
| – | -$8K | – | 6711 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6193 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6185 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6336 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6376 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6406 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6365 |
|
Other funds holding NCNA
SG
GJIA
IWC
CIAM
SS
Morgan Stanley's NCNA Position: Q2 2026 in Review
Morgan Stanley held its NuCana (NCNA) position steady in Q2 2026 at 2 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #8377.
Morgan Stanley first reported a position in NCNA in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.24M in Q2 2021. 9 funds tracked by Wall St. Rank hold NCNA as of Q2 2026.
- Morgan Stanley held 2 shares of NuCana worth $3 as of Q2 2026.
- Morgan Stanley left its NuCana share count unchanged in Q2 2026.
- NuCana made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #8377 holding.
- Morgan Stanley first reported a position in NuCana in Q2 2021 and has held it in 13 quarters since.
- Morgan Stanley's NuCana position peaked at $1.24M in Q2 2021.
- 9 funds tracked by Wall St. Rank held NuCana as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.